???global.info.a_carregar???
Vanessa Cardoso Pires Martins Correia. Completed the Doutoramento in Ciências e Tecnologias da Saúde in 2018/01/25 by Universidade de Lisboa Faculdade de Medicina and Licenciatura in Biologia in 2006/12/13 by Universidade de Évora. Is Researcher in Instituto Nacional de Saúde Doutor Ricardo Jorge. Published 11 articles in journals. Organized 1 event(s). Participated in 12 event(s). Has received 4 awards and/or honors. Participates and/or participated as Integration into Research Grant Fellow in 3 project(s), Pos-doctoral Fellow in 1 project(s) and Researcher in 1 project(s). Works in the area(s) of Medical and Health Sciences with emphasis on Health Sciences with emphasis on Infectious Diseases and Natural sciences with emphasis on Biological Sciences with emphasis on Virology. In his curriculum Ciência Vitae the most frequent terms in the context of scientific, technological and artistic-cultural output are: Viral infections; Influenza virus; Antivirals; Antiviral Resistance; Antiviral Activity; Novel antiviral targets; Molecular Virology; Virus Evolution; Genetics & Phylogenetics; Selective Pressure; and Computational biology.
Identification

Personal identification

Full name
Vanessa Cardoso Pires Martins Correia

Citation names

  • Correia, Vanessa
  • Correia, V.

Author identifiers

Ciência ID
391A-1FCC-59C2
ORCID iD
0000-0002-1619-1900
Researcher Id
V-2507-2017
Scopus Author Id
54585076000

Email addresses

  • vanessa.correia@insa.min-saude.pt (Professional)
  • vanessacpmcorreia@hotmail.com (Personal)

Addresses

  • Instituto Nacional de Saúde Dr. Ricardo Jorge, Antiviral Resistance Lab, Research and Development Unit, Infectious Diseases Department, Avenida Padre Cruz, 1649-016, Lisbon, Lisbon, Portugal (Professional)

Knowledge fields

  • Natural sciences - Biological Sciences - Virology
  • Medical and Health Sciences - Health Sciences - Infectious Diseases

Languages

Language Speaking Reading Writing Listening Peer-review
English Advanced (C1) Proficiency (C2) Proficiency (C2) Proficiency (C2) Advanced (C1)
Spanish; Castilian Elementary (A2) Intermediate (B1) Elementary (A2) Intermediate (B1) Elementary (A2)
French Beginner (A1) Elementary (A2) Beginner (A1) Elementary (A2) Beginner (A1)
Education
Degree Classification
2009/10/01 - 2018/01/25
Concluded
Ciências e Tecnologias da Saúde (Doutoramento)
Major in Microbiology
Universidade de Lisboa Faculdade de Medicina, Portugal
"Influenza Virus Susceptibility to Antiviral Drugs – Drug Susceptibility Profiling, Whole-genome Mutational Landscape and Selective Pressure Footprints" (THESIS/DISSERTATION)
2001/09/01 - 2006/12/13
Concluded
Biologia (Licenciatura)
Universidade de Évora, Portugal
"Caracterização e filogenia do gene da neuraminidase dos vírus influenza" (THESIS/DISSERTATION)
17
Affiliation

Science

Category
Host institution
Employer
2020/01/01 - Current Researcher (Research) Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
2015/01/01 - 2017/12/31 Researcher (Research) Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
2012/01/01 - 2013/12/31 Researcher (Research) Universidade de Lisboa Faculdade de Farmácia, Portugal
2005/03/10 - 2006/10/06 Research Trainee (Research) Universidade de Évora, Portugal
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal

Other Careers

Category
Host institution
Employer
2021/04/15 - Current Técnico Superior (Técnico Superior) Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal

Others

Category
Host institution
Employer
2016/12/15 - 2021/04/14 Service provider in R&D activities Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2013/02/02 - 2015/10/31 Research fellowship Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2009/10/01 - 2013/09/30 PhD Student research fellowship Fundação para a Ciência e a Tecnologia, Portugal
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2007/01/15 - 2009/09/30 Research fellowship Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
Projects

Grant

Designation Funders
2020 - 2021/07/05 Repurposed antimalarial and anti-Ebola drugs as Organic Salts and Ionic Liquids to prevent and fight COVID-19
Research 4 COVID-19 nº 582
Researcher
Associação para a Inovação e Desenvolvimento da FCT, Portugal
Fundação para a Ciência e a Tecnologia
Concluded

Contract

Designation Funders
2020 - 2023/12/31 Research Institute for Medicines
UIDB/04138/2020
Researcher
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Ongoing
2018 - 2022/08/31 Reverse Genetics Vaccine Seeds for Influenza: Mechanisms that drive the co-segregation of PB1 with antigenic proteins
PTDC/SAU-INF/30729/2017
Researcher
Universidade de Lisboa Faculdade de Farmácia, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2009 - 2015/10/31 Evaluation and characterization of the emergence of resistance to influenza antiviral drugs in the context of acute respiratory infection
FCG SDH49
Integration into Research Grant Fellow
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
Fundação Calouste Gulbenkian
Concluded
2012 - 2015/09/10 Functional compatibility of the replication complex as determinant of virulence in influenza viruses
PTDC/SAUMIC/122780/2010
Researcher
Universidade de Lisboa Faculdade de Farmácia, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2007 - 2009/10/30 Monitoring and surveillance of the susceptibility to influenza antiviral drugs
FCG 76676
Integration into Research Grant Fellow
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
Fundação Calouste Gulbenkian
Concluded

Other

Designation Funders
2013 - 2014/04/30 Influence of the stress in the immunity response to influenza vaccine in health care professionals
ENSP 033Has
Integration into Research Grant Fellow
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
Universidade Nova de Lisboa Escola Nacional de Saúde Pública
Concluded
Outputs

Publications

Conference paper
  1. Correia, Vanessa; Rebelo-de-Andrade, Helena. "Evolution of human influenza A virus neuraminidase gene and evaluation of susceptibility to antivirals". Paper presented in Options for the Control of Influenza VI, Toronto, 2007.
    Published
Conference poster
  1. Trigueiro-Louro, João; Figueiredo-Nunes, Inês; Santos, Luís A.; Almeida, Filipe; Correia, Vanessa; Guedes, Rita C.; Brito, Rui M.M.; Rebelo-de-Andrade, Helena. "Exploring influenza A and B therapeutics: NS1 as a potential universal antiviral target". Paper presented in The seventh ESWI Influenza Conference, Virtual Edition, 2020.
  2. Trigueiro-Louro, João; Santos, Luís A.; Almeida, Filipe; Correia, Vanessa; Brito, Rui M.M.; Rebelo-de-Andrade, Helena. "NS1 as a promising anti-influenza target: new putative druggable hot spots and their relevance on viral replication". Paper presented in The seventh ESWI Influenza Conference, Virtual Edition, 2020.
  3. Trigueiro-Louro, João; Correia, Vanessa; Figueiredo-Nunes, Inês; Gíria, Marta; Rebelo-de-Andrade, Helena. "Exploring coronavirus locks: Sequence-to-structure characterization of SARS-CoV-2, SARS-CoV and MERS-CoV proteins". Paper presented in The seventh ESWI Influenza Conference, Virtual Edition, 2020.
  4. Figueiredo-Nunes, Inês; Trigueiro-Louro, João; Correia, Vanessa; Gíria, Marta; Rebelo-de-Andrade, Helena. "Exploring antiviral strategies against a broad range of beta-CoVs: Spike and Polymerase proteins as promising anti-CoV targets". Paper presented in Special isirv-AVG Virtual Conference on “Therapeutics for COVID-19”, 2020.
  5. Correia, Vanessa; Santos, Luís A.; Trigueiro-Louro, João; Abecasis, Ana; Rebelo-de-Andrade, Helena. "Victoria and Yamagata: Exploiting lineage-specificity of influenza B virus neuraminidase inhibitor natural susceptibility and selective pressure strength at resistance-associated sites". Paper presented in OPTIONS X for the Control of Influenza, 2019.
  6. Trigueiro-Louro, João; Gíria, Marta; Santos, Luís A.; Correia, Vanessa; Rebelo-de-Andrade, Helena. "PB1-HA functional compatibility contributes to genome segregation patterns and to the overall viral fitness in A(H1N1)pdm09 vaccine seeds". Paper presented in OPTIONS X for the Control of Influenza, 2019.
  7. Trigueiro-Louro, João; Santos, Luís A.; Correia, Vanessa; Guedes, Rita; Rebelo-de-Andrade, Helena. "Unlocking the antiviral target potential of influenza A virus NS1 protein". Paper presented in OPTIONS X for the Control of Influenza, 2019.
  8. Trigueiro-Louro, João; Correia, Vanessa; Santos, Luís A.; Guedes, Rita; Rebelo-de-Andrade, Helena. "Na rota dos descobrimentos de novos alvos antivirais contra a gripe - Mapeamento computacional do domínio efetor da proteína NS1". Paper presented in V Congresso Nacional de Virologia, 2018.
  9. David, Susana; Correia, Vanessa; Antunes, Liliana; Faria, R.; Ferrão, José; Faustino, Paula; Nunes, Baltazar; et al. "Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity". Paper presented in 21a Reunião Anual da Sociedade Portuguesa de Genética Humana (SPGH), 2017.
  10. Trigueiro-Louro, João; Correia, Vanessa; Rebelo-de-Andrade, Helena. "A cost-efficient solution: reagent comparison guide for neuraminidase inhibition assay". Paper presented in 19th Annual Meeting of the European Society for Clinical Virology, 2016.
    10.5594/m001597
  11. Correia, Vanessa; Abecasis, Ana; Rebelo-de-Andrade, Helena. "Uncovering the role of positive selection in the evolutionary pathways to influenza virus resistance or reduced inhibition by neuraminidase inhibitors". Paper presented in Options IX for the Control of Influenza, 2016.
  12. Correia, Vanessa; Santos, Luís A.; Gíria, Marta; Rebelo-de-Andrade, Helena. "Evaluation and Characterization of Influenza Antiviral Drug Resistance in Portugal: Major Results and Achievements of a 5-Year Study". Paper presented in The second conference of the isirv-Antiviral Group (isirv-AVG) “Severe Influenza: Burden, Pathogenesis and Management”, 2012.
  13. Santos, Luís A.; Solá, Susana; Correia, Vanessa; Gíria, Marta; Rodrigues, Cecília MP; Rebelo-de-Andrade, Helena. "Different Mechanisms of Apoptosis by Influenza A and B Virus". Paper presented in The second conference of the isirv-Antiviral Group (isirv-AVG) “Severe Influenza: Burden, Pathogenesis and Management”, 2012.
  14. Correia, Vanessa; Santos, Luís A.; Sousa Uva, Mafalda; Rebelo-de-Andrade, Helena. "Emergência de resistência aos antivirais específicos para a gripe: determinação do perfil antivírico de vírus influenza sazonais e da nova variante pandémica A(H1N1)v circulantes em Portugal". Paper presented in 7as Jornadas de Actualização em Doenças Infecciosas do Hospital de Curry Cabral, 2010.
  15. Correia, Vanessa; Rebelo-de-Andrade, Helena; Santos, Luís A.; Gíria, Marta. "Monitoring influenza antiviral susceptibility in Portugal from 2004/2005 to 2007/2008 winter seasons". Paper presented in The Third European Influenza Conference, 2008.
  16. Correia, Vanessa; Rebelo-de-Andrade, Helena; Santos, Luís A.; Gíria, Marta. "Susceptibility to oseltamivir and amantadine of human influenza viruses circulating in Portugal". Paper presented in 13th International Congress on Infectious Diseases, 2008.
  17. Correia, Vanessa; Rebelo-de-Andrade, Helena. "Evolution of human influenza A virus neuraminidase gene and evaluation of susceptibility to antivirals". Paper presented in Options for the Control of Influenza VI, 2007.
Journal article
  1. Faísca, Francisco; Correia, Vanessa; Petrovski, Zeljko; Branco, Luis C; Rebelo-de-Andrade, Helena; Santos, Miguel M. "Enhanced antiviral activity of Hydroxychloroquine Ionic Liquids against SARS-CoV-2". Pharmaceutics (2022):
    Under revision
  2. Trigueiro-Louro, João; Santos, Luís A.; Almeida, Filipe; Correia, Vanessa; Brito, Rui M.M.; Rebelo-de-Andrade, Helena. "NS1 protein as a novel anti-influenza target: Map-and-mutate antiviral rationale reveals new putative druggable hot spots with an important role on viral replication". Virology 565 (2022): 106-116. http://dx.doi.org/10.1016/j.virol.2021.11.001.
    10.1016/j.virol.2021.11.001
  3. Trigueiro-Louro, João; Correia, Vanessa; Figueiredo-Nunes, Inês; Gíria, Marta; Rebelo-de-Andrade, Helena. "Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike". Computational and Structural Biotechnology Journal 18 (2020): 2117-2131. http://dx.doi.org/10.1016/j.csbj.2020.07.017.
    10.1016/j.csbj.2020.07.017
  4. Trigueiro-Louro, João M.; Correia, Vanessa; Santos, Luís A.; Guedes, Rita C.; Brito, Rui M.M.; Rebelo-de-Andrade, Helena. "To hit or not to hit: Large-scale sequence analysis and structure characterization of influenza A NS1 unlocks new antiviral target potential". Virology 535 (2019): 297-307. http://dx.doi.org/10.1016/j.virol.2019.04.009.
    10.1016/j.virol.2019.04.009
  5. Correia V; Abecasis AB; Rebelo-de-Andrade H. "Molecular footprints of selective pressure in the neuraminidase gene of currently circulating human influenza subtypes and lineages.". Virology (2018): http://europepmc.org/abstract/med/30029011.
    10.1016/j.virol.2018.07.002
  6. David, Susana; Correia, Vanessa; Antunes, Liliana; Faria, R.; Ferrão, José; Faustino, Paula; Nunes, Baltazar; et al. "Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity.". Immunogenetics (2017): http://europepmc.org/abstract/med/28842783.
    10.1007/s00251-017-1026-2
  7. Correia, Vanessa; Santos, Luís A.; Gíria, Marta; Santos, Madalena M.; Rebelo-de-Andrade, Helena. "Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs.". Journal of Medical Virology (2015): http://europepmc.org/abstract/med/25042157.
    10.1002/jmv.23986
  8. Adam Meijer; Helena Rebelo-de-Andrade; Vanessa Correia; Terry Besselaar; Renu Drager-Dayal; Alicia Fry; Vicky Gregory; et al. "Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012–2013". Antiviral Research 110 (2014): 31-41. https://doi.org/10.1016/j.antiviral.2014.07.001.
    10.1016/j.antiviral.2014.07.001
  9. Gíria, Marta; Rebelo-de-Andrade, Helena; Santos, Luís A.; Correia, Vanessa; Pedro, Sónia; Santos, Madalena M.. "Genomic signatures and antiviral drug susceptibility profile of A(H1N1)pdm09.". Journal of Clinical Virology (2012): http://europepmc.org/abstract/med/22177272.
    10.1016/j.jcv.2011.11.002
  10. Santos, Luís A.; Correia, Vanessa; Gíria, Marta; Pedro, Sónia; Santos, Madalena M.; Silvestre, Maria J.; Rebelo-de-Andrade, Helena. "Genetic and Antiviral Drug Susceptibility Profiles of Pandemic A(H1N1)v Influenza Virus Circulating in Portugal". Influenza and Other Respiratory Viruses (2011):
    DOI:10.1111/j.1750-2659.2011.00221.x
  11. Correia, Vanessa; Rebelo-de-Andrade, Helena; Santos, Luís A.; Lackenby, Angie; Zambon, Maria. "Antiviral drug profile of seasonal influenza viruses circulating in Portugal from 2004/2005 to 2008/2009 winter seasons.". Antiviral Research (2010): http://europepmc.org/abstract/med/20083142.
    10.1016/j.antiviral.2010.01.002
  12. Santos, Luís A.; Correia, Vanessa; Pedro, Sónia; Alverca, Elsa; Santos, Madalena M.; Silvestre, Maria J.; Rebelo-de-Andrade, Helena. "Caracterização genética da nova variante pandémica do vírus influenza A(H1N1) 2009 em circulação em Portugal: resultados preliminares". Revista Portuguesa de Doenças Infecciosas 6 1 (2010): 7-13.
    Published
  13. Correia, Vanessa; Santos, Luís A.; Rebelo-de-Andrade, Helena. "Emergência de resistência aos antivirais específicos para a gripe em Portugal". Revista Portuguesa de Doenças Infecciosas 5 1 (2009): 17-24.
    Published
Magazine article
  1. Correia, Vanessa; Lourenço, Joana; Albuquerque, Sara. "Prevenção do cancro do colo do útero através da vacinação com virossomas – artigo de revisão", Mundo farmacêutico, 2005
Newsletter article
  1. David, Susana; Correia, Vanessa; Antunes, Liliana; Faria, R; Ferrão, José; Faustino, Paula; Nunes, Baltazar; et al. "Variantes genéticas do gene IFITM3 revelam um potencial modificador da gravidade sintomática da gripe", Boletim epidemiológico Observações, Instituto Nacional de Saúde Doutor Ricardo Jorge, 2018
  2. Correia, Vanessa; Santos, Luís A.; Rebelo-de-Andrade, Helena. "Perfil de suscetibilidade do vírus influenza aos antivirais específicos para a gripe de 2004 a 2011", Boletim epidemiológico Observações, Instituto Nacional de Saúde Doutor Ricardo Jorge, 2013
Thesis / Dissertation
  1. Correia, Vanessa. "Influenza Virus Susceptibility to Antiviral Drugs – Drug Susceptibility Profiling, Whole-genome Mutational Landscape and Selective Pressure Footprints". PhD, Universidade de Lisboa Faculdade de Medicina, 2018.
  2. Correia, Vanessa. "Caracterização e filogenia do gene da neuraminidase dos vírus influenza". Degree, Universidade de Évora, 2006.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2014/11/03 Selective pressure acting on influenza neuraminidase gene: a complementary approach for studying the emergence and evolution of antiviral drug resistance and reduced susceptibility International Meeting on Emerging Diseases and Surveillance (IMED)
(Vienna, Austria)
2014/10/03 Large-scale differential selection analysis on influenza A and B neuraminidase gene: a new approach for studying antiviral drug resistance and reduced susceptibility III International Conference on Antimicrobial Research (ICAR)
(Madrid, Spain)
2012/11/30 Susceptibility of influenza viruses to antiviral drugs VI PhD Students Meeting IMM/CAML
Instituto de Medicina Molecular João Lobo Antunes (Lisbon, Portugal)
2011/11/26 Susceptibilidade dos vírus influenza aos antivirais específicos para a gripe Journal Club
Instituto Nacional de Saúde Dr. Ricardo Jorge, Departamento de Doenças Infecciosas (Lisbon, Portugal)
2011/07/07 Training Course to Testing: Portugal Perspective CNRL Influenza Antiviral Susceptibility Surveillance Training Course
Public Health England, Colindale (London, United Kingdom)
2010/09/06 Genetic and Antiviral Drug Susceptibility Profiles of Pandemic A(H1N1)v Influenza Virus Circulating in Portugal Options for the Control of Influenza VII
(Hong Kong SAR, China)
2009/12/09 Emergência de resistência aos antivirais específicos para a gripe Workshop “Gripe”, VI Ciclo de Workshops AEFFUL-GIPES
Universidade de Lisboa, Faculdade de Farmácia (Lisbon, Portugal)
2009/11/13 A globalização e a emergência de novos vírus - Emergência de resistências aos antivirais específicos para a gripe III Jornadas Nacionais de Controlo da Infecção da Associação Nacional de Controlo de Infecção
Associação Nacional de Controlo de Infecção (Guimarães, Portugal)
2009/11/07 Gripe sazonal e pandémica: emergência de resistências III Congresso Nacional de Virologia/VII Encontro da Sociedade Portuguesa de Virologia
Sociedade Portuguesa de Virologia (Lisbon, Portugal)
2008/12/02 Gripe: aspectos de uma doença re(emergente) III Congresso Científico Anual do Núcleo de Estudantes de Farmácia da Associação Académica de Coimbra “Na Era do Terrorismo: Doenças Infecciosas”
Universidade de Coimbra, Faculdade de Farmácia (Coimbra, Portugal)
2007/11/09 Preliminary results on the evaluation of the susceptibility to antivirals of influenza viruses isolated in Portugal VIRGIL Influenza Antiviral Data Handling Workshop
Public Health England, Colindale (London, United Kingdom)
2007/09/22 Novos antivíricos no controlo da gripe II Congresso Nacional de Virologia/VI Encontro da Sociedade Portuguesa de Virologia
Sociedade Portuguesa de Virologia (Porto, Portugal)

Event organisation

Event name
Type of event (Role)
Institution / Organization
2011/06/05 - 2011/06/08 “CNRL Influenza Antiviral Susceptibility Surveillance Training Course”, organised under the auspices of the Community Network of Reference Laboratories for Human Influenza in Europe (CNRL) and the European Centre for Disease Prevention and Control (ECDC). (2011/06/05 - 2011/06/08)
Workshop (Other)
Public Health England Colindale, United Kingdom

National Institute for Medical Research, United Kingdom

Event participation

Activity description
Type of event
Event name
Institution / Organization
2018/11/15 - 2018/11/16 Attendee at the course “Transporte de substâncias infeciosas", organised by the Emergency Response and Bio-Preparedness Unit, Department of Infectious Diseases, INSA, IP, under the models and regulations of WHO (WHO certified)
Workshop
Transporte de substâncias infeciosas (5ª ed)
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2018/11/12 - 2018/11/14 Attendee at the training course “Biossegurança em laboratórios de nível 2 e 3 ", organised by the Emergency Response and Bio-Preparedness Unit, Department of Infectious Diseases, INSA, IP
Workshop
Biossegurança em laboratórios de nível 2 e 3 (10ª ed)
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2013/02/26 - 2013/03/22 Attendee at the advanced Course “Applied Biostatistics”, Lisbon Academic Medical Centre (CAML) Doctoral Programme
Workshop
Applied Biostatistics
Universidade de Lisboa Faculdade de Medicina, Portugal
2012/11/26 - 2012/11/26 Attendee at the advanced Course “Scientific Career Development 101”, Lisbon Academic Medical Centre (CAML) Doctoral Programme
Workshop
Scientific Career Development 101
Universidade de Lisboa Faculdade de Medicina, Portugal
2012/08/27 - 2012/08/31 Attendee at the “17th International Bioinformatics Workshop on Virus Evolution and Molecular Epidemiology”, Evolutionary and Hypothesis Testing Advanced Module, held at Faculty of Medicine, University of Belgrade, Belgrade
Workshop
17th International Bioinformatics Workshop on Virus Evolution and Molecular Epidemiology
Katholieke Universiteit Leuven Rega Institute for Medical Research, Belgium

Medicinski fakultet Univerzitet u Beogradu, Serbia
2012/04/12 - 2012/04/13 Attendee at the advanced Course “Get the best from your sequences”, Lisbon Academic Medical Centre (CAML) Doctoral Programme
Workshop
Get the best from your sequences
Universidade de Lisboa Faculdade de Medicina, Portugal
2011/07/11 - 2011/07/15 Training at the Respiratory Virus Unit, Virus Reference Department, Health Protection Agency (HPA), Colindale, London, UK, in a new protocol of plaque reduction assay for virus titration (pfu/ml)
Other
Public Health England Colindale, United Kingdom
2011/07/14 - 2011/07/14 Training at the WHO Collaborating Center for Reference and Research on Influenza, NIMR, The Ridgeway, Mill Hill, London, UK, in new reference protocols of hemagglutination assay and hemagglutination inhibition assay with oseltamivir
Other
National Institute for Medical Research, United Kingdom
2009/04/20 - 2009/04/21 Attendee at the seminar “Molecular Detection of Pathogens”, with Doctor Andreas Nitsche, Robert Koch Institute, Berlin, Germany, as speaker
Seminar
Molecular Detection of Pathogens
Instituto Politécnico de Setúbal, Portugal
2007/11/09 - 2007/11/09 Invited participation at the “VIRGIL Influenza Antiviral Data Handling” workshop, organized under the umbrella of the European Surveillance Network for Vigilance against Viral Resistance (VIRGIL)
Workshop
VIRGIL Influenza Antiviral Data Handling
Public Health England Colindale, United Kingdom
2007/08/27 - 2007/09/14 Training at the Respiratory Virus Unit, Virus Reference Department, Health Protection Agency (HPA), Colindale, London, UK, in genotypic evaluation of influenza virus susceptibility to M2 protein inhibitors by pyrosequencing methodology, and statistical analysis of phenotypic antiviral susceptibility assay data
Other
Public Health England Colindale, United Kingdom
2006/10/03 - 2006/10/06 Attendee at the “VIRGIL Training Course on Laboratory Methods for Antiviral Susceptibility”, organized by the European Surveillance Network for Vigilance against Viral Resistance (VIRGIL)
Workshop
VIRGIL Training Course on Laboratory Methods for Antiviral Susceptibility
Public Health England Colindale, United Kingdom

Course / Discipline taught

Academic session Degree Subject (Type) Institution / Organization
2011 - 2012 Assistant of Prof. Helena Rebelo de Andrade in the practical sessions within Virology discipline Integrated Master in Pharmaceutical Sciences (Mestrado integrado) Universidade de Lisboa Faculdade de Farmácia, Portugal
2010 - 2011 Assistant of Prof. Helena Rebelo de Andrade in the practical sessions within Virology discipline Integrated Master in Pharmaceutical Sciences (Mestrado integrado) Universidade de Lisboa Faculdade de Farmácia, Portugal
2004 - 2005 Assistant of Prof. Carlos Sinogas in the practical sessions within Biotechnology discipline BSc (Hons) in Biology (Licenciatura) Universidade de Évora, Portugal

Mentoring / Tutoring

Topic Student name
2017/01/01 - Current Assistance, training and support in the supervision of Phd works João Manuel Trigueiro Louro
2017/03/05 - 2017/03/20 Training in safety and biosafety management issues and procedures in a Biosafety level 2 laboratory Gabriela Simões
2013/11/12 - 2013/11/16 Theoretical and practical training in influenza antiviral susceptibility testing Members of the National Influenza Center, Public Health Institutions of Turkey
2008/09/22 - 2009/10/02 Theoretical and practical training and support in supervision of the works for Master degree Mafalda Bernes de Sousa Uva
2007/11/26 - 2007/11/29 Practical training in influenza antiviral susceptibility testing Guillermo Ruiz, National Center for Microbiology, Instituto de Salud Carlos III
Distinctions

Other distinction

2008 Award “Student of the year” (student with the highest final grade)
Universidade de Évora, Portugal
2005 Award of Merit - year 2004/2005
Universidade de Évora, Portugal
2004 Award of Merit - year 2003/2004
Universidade de Évora, Portugal
2002 Award of Merit - year 2001/2002
Universidade de Évora, Portugal